TrialPulmonary pharmacology & therapeutics2008

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study.

Nicola A Hanania et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.